Rob, see exrtact and check out the links below:
Once the IND is submitted, the sponsor must wait 30 calendar days before initiating any clinical trials. During this time, FDA has an opportunity to review the IND for safety to assure that research subjects will not be subjected to unreasonable risk.
http://www.fda.gov/cder/Regulatory/applications/ind_page_1.htm
http://www.fda.gov/CDER/HANDBOOK/DEVELOP.HTM
prima biomed back in the spotlight, page-18
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
0.068(22.9%) |
Mkt cap ! $512.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $4.628M | 12.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 187224 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 290747 | 7 |
View Market Depth
| Last trade - 12.22pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |